autologous anti-PSMA gene-modified T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011495
Autologous prostate specific membrane antigen (PSMA) gene-modified T lymphocytes with potential antineoplastic activity. Human autologous T lymphocytes are isolated and transduced ex vivo with a retrovirus encoding a chimeric immune receptor (CIR) consisting of an antibody fragment against PSMA fused with signaling domains of the T cell. Upon reintroduction into the patient, autologous anti-PSMA gene-modified T cells bind to PSMA-expressing prostate cancer cells, which may result in specific cytotoxic T-lymphocyte (CTL) tumor cell killing.
| Identifier | MLC-T-ONC-011495 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous anti-prostate-specific membrane antigen gene-modified T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011495",
"term": "autologous anti-PSMA gene-modified T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "Autologous prostate specific membrane antigen (PSMA) gene-modified T lymphocytes with potential antineoplastic activity. Human autologous T lymphocytes are isolated and transduced ex vivo with a retrovirus encoding a chimeric immune receptor (CIR) consisting of an antibody fragment against PSMA fused with signaling domains of the T cell. Upon reintroduction into the patient, autologous anti-PSMA gene-modified T cells bind to PSMA-expressing prostate cancer cells, which may result in specific cytotoxic T-lymphocyte (CTL) tumor cell killing.",
"synonyms": [
"autologous anti-prostate-specific membrane antigen gene-modified T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-psma-gene-modified-t-lymphocytes/"
}
Record 2,827 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.